These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1132 related items for PubMed ID: 30043534
1. Substantial variation exists in spirometry interpretation practices for airflow obstruction in accredited lung function laboratories across Australia and New Zealand. Holt NR, Thompson BR, Miller B, Borg BM. Intern Med J; 2019 Jan; 49(1):41-47. PubMed ID: 30043534 [Abstract] [Full Text] [Related]
3. FEV1/FVC and FEV1 for the assessment of chronic airflow obstruction in prevalence studies: do prediction equations need revision? Roche N, Dalmay F, Perez T, Kuntz C, Vergnenègre A, Neukirch F, Giordanella JP, Huchon G. Respir Med; 2008 Nov; 102(11):1568-74. PubMed ID: 18657959 [Abstract] [Full Text] [Related]
4. Bronchodilator Response in FVC Is Larger and More Relevant Than in FEV1 in Severe Airflow Obstruction. Quanjer PH, Ruppel GL, Langhammer A, Krishna A, Mertens F, Johannessen A, Menezes AMB, Wehrmeister FC, Perez-Padilla R, Swanney MP, Tan WC, Bourbeau J. Chest; 2017 May; 151(5):1088-1098. PubMed ID: 28040521 [Abstract] [Full Text] [Related]
7. Bronchodilator reversibility testing: laboratory practices in Australia and New Zealand. Borg BM, Reid DW, Walters EH, Johns DP. Med J Aust; 2004 Jun 21; 180(12):610-3. PubMed ID: 15200356 [Abstract] [Full Text] [Related]
9. A Comparison of Global Lung Initiative 2012 with Third National Health and Nutrition Examination Survey Spirometry Reference Values. Implications in Defining Obstruction. Huprikar NA, Holley AB, Skabelund AJ, Hayes JA, Hiles PD, Aden JK, Morris MJ, Hersh AM. Ann Am Thorac Soc; 2019 Feb 21; 16(2):225-230. PubMed ID: 30427734 [Abstract] [Full Text] [Related]
10. Combined Forced Expiratory Volume in 1 Second and Forced Vital Capacity Bronchodilator Response, Exacerbations, and Mortality in Chronic Obstructive Pulmonary Disease. Fortis S, Comellas A, Make BJ, Hersh CP, Bodduluri S, Georgopoulos D, Kim V, Criner GJ, Dransfield MT, Bhatt SP, COPDGene Investigators–Core Units: <italic>Administrative Center</italic>, COPDGene Investigators–Clinical Centers: <italic>Ann Arbor VA</italic>. Ann Am Thorac Soc; 2019 Jul 21; 16(7):826-835. PubMed ID: 30908927 [Abstract] [Full Text] [Related]
11. Combining small airway parameters with conventional parameters obtained during spirometry to diagnose airflow obstruction: A cross-sectional study. Wang Z, Lin J, Liang L, Li Y, Huang J, Gao Y, Zheng J. Respirology; 2024 Jul 21; 29(7):605-613. PubMed ID: 38657967 [Abstract] [Full Text] [Related]
12. Lower limit of normal or FEV1/FVC < 0.70 in diagnosing COPD: an evidence-based review. Mohamed Hoesein FA, Zanen P, Lammers JW. Respir Med; 2011 Jun 21; 105(6):907-15. PubMed ID: 21295958 [Abstract] [Full Text] [Related]
13. Heterogeneous burden of lung disease in smokers with borderline airflow obstruction. Pirozzi CS, Gu T, Quibrera PM, Carretta EE, Han MK, Murray S, Cooper CB, Tashkin DP, Kleerup EC, Barjaktarevic I, Hoffman EA, Martinez CH, Christenson SA, Hansel NN, Graham Barr R, Bleecker ER, Ortega VE, Martinez FJ, Kanner RE, Paine R, NHLBI SubPopulations and InteRmediate Outcome Measures In COPD Study (SPIROMICS). Respir Res; 2018 Nov 20; 19(1):223. PubMed ID: 30454050 [Abstract] [Full Text] [Related]
18. Measures of bronchodilator response of FEV1, FVC and SVC in a Swedish general population sample aged 50-64 years, the SCAPIS Pilot Study. Torén K, Bake B, Olin AC, Engström G, Blomberg A, Vikgren J, Hedner J, Brandberg J, Persson HL, Sköld CM, Rosengren A, Bergström G, Janson C. Int J Chron Obstruct Pulmon Dis; 2017 Jul 20; 12():973-980. PubMed ID: 28356729 [Abstract] [Full Text] [Related]
19. Spirometric criteria for airway obstruction: Use percentage of FEV1/FVC ratio below the fifth percentile, not < 70%. Hansen JE, Sun XG, Wasserman K. Chest; 2007 Feb 20; 131(2):349-55. PubMed ID: 17296632 [Abstract] [Full Text] [Related]
20. Predicting inadequate spirometry technique and the use of FEV1/FEV3 as an alternative to FEV1/FVC for patients with mild cognitive impairment. Allen S, Yeung P, Janczewski M, Siddique N. Clin Respir J; 2008 Oct 20; 2(4):208-13. PubMed ID: 20298336 [Abstract] [Full Text] [Related] Page: [Next] [New Search]